Institutional Ownership
Immunitybio Inc
CUSIP 45256X103COMIBRXQ1 2026
13D / 13G Filings
7
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
68.9%
Max % of class reported
Institutional Holders
378
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
7 filings · latest Feb 25, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 25, 2026 | Cambridge Equities, LP | 13D/A | 66.3% | — | SEC |
| 2 | Nov 10, 2025 | Cambridge Equities, LP | 13D/A | 68.9% | — | SEC |
| 3 | Jan 4, 2024 | Cambridge Equities, LP | 13D/A | 39.0% | 261.71M | SEC |
| 4 | Sep 21, 2023 | Cambridge Equities, LP | 13D/A | 39.2% | 261.71M | SEC |
| 5 | May 23, 2023 | Cambridge Equities, LP | 13D/A | 60.0% | 261.71M | SEC |
| 6 | Dec 7, 2022 | Cambridge Equities, LP | 13D/A | 65.4% | 261.71M | SEC |
| 7 | Mar 12, 2021 | Cambridge Equities, LP | 13D/A | 68.4% | 261.71M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 26.35M | $202.08M |
| 2 | State Street Corp | 17.71M | $135.82M |
| 3 | D. E. Shaw & Co., Inc. | 12.57M | $96.42M |
| 4 | Geode Capital Management, LLC | 8.03M | $61.62M |
| 5 | Two Sigma Investments, LP | 4.39M | $33.64M |
| 6 | Morgan Stanley | 4.02M | $30.82M |
| 7 | Woodline Partners LP | 3.45M | $26.44M |
| 8 | Goldman Sachs Group Inc | 3.24M | $24.83M |
| 9 | Ubs Group AG | 2.94M | $22.59M |
| 10 | Voloridge Investment Management, LLC | 2.93M | $22.45M |